169 related articles for article (PubMed ID: 38459589)
21. Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?
Zheng LQ; Huang Y; Han XC
J Cutan Pathol; 2013 May; 40(5):509-12. PubMed ID: 23418925
[TBL] [Abstract][Full Text] [Related]
22. A 28-Year-Old Male Patient with Nail Tumors, Skin Lesions, and Epilepsy.
Balak DM; Zonnenberg BA; Spitzer-Naaijkens JM; Hulshof MM
Case Rep Dermatol; 2017; 9(1):12-19. PubMed ID: 28203158
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex with oral manifestations: a case report and literature review.
Harutunian K; Figueiredo R; Gay-Escoda C
Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e478-81. PubMed ID: 20711158
[TBL] [Abstract][Full Text] [Related]
24. Tuberous Sclerosis.
Amorim BDB; Azulay D; Ramos-E-Silva M
Skinmed; 2021; 19(3):179-185. PubMed ID: 34303387
[TBL] [Abstract][Full Text] [Related]
25. Analysis of twenty pediatric cases of tuberous sclerosis complex: are we doing enough?
Nath J; Dubey A; Pavan R
Indian J Dermatol Venereol Leprol; 2015; 81(1):23-8. PubMed ID: 25566892
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous Manifestations of Tuberous Sclerosis.
Bakić M; Ratković M; Gledović B; Vujović B; Radunović D; Babić V; Prelević V
Acta Dermatovenerol Croat; 2018 Apr; 26(1):73-74. PubMed ID: 29782307
[TBL] [Abstract][Full Text] [Related]
27. [Eyelid and cutaneous lesions as the sole indicators of tuberous sclerosis].
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Ricoy JR; Sánez-Madrazo N
Arch Soc Esp Oftalmol; 2004 Aug; 79(8):401-4. PubMed ID: 15306968
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis in a patient from Nigeria.
Ekure EN; Addissie YA; Sokunbi OJ; Kruszka P; Muenke M; Adeyemo AA
Am J Med Genet A; 2019 Aug; 179(8):1423-1425. PubMed ID: 31140686
[TBL] [Abstract][Full Text] [Related]
29. Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.
Teng JM; Cowen EW; Wataya-Kaneda M; Gosnell ES; Witman PM; Hebert AA; Mlynarczyk G; Soltani K; Darling TN
JAMA Dermatol; 2014 Oct; 150(10):1095-101. PubMed ID: 25029267
[TBL] [Abstract][Full Text] [Related]
30. Odontogenic myxofibroma of gingiva in a pediatric patient with tuberous sclerosis: A rare case report.
Bhoyar N; Gupta S; Ghosh S
Contemp Clin Dent; 2016; 7(4):558-561. PubMed ID: 27994429
[TBL] [Abstract][Full Text] [Related]
31. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.
Tyburczy ME; Wang JA; Li S; Thangapazham R; Chekaluk Y; Moss J; Kwiatkowski DJ; Darling TN
Hum Mol Genet; 2014 Apr; 23(8):2023-9. PubMed ID: 24271014
[TBL] [Abstract][Full Text] [Related]
32. Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Boggarapu S; Roberds SL; Nakagawa J; Beresford E
Orphanet J Rare Dis; 2022 Sep; 17(1):355. PubMed ID: 36104799
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of two neurocutaneous syndromes: tuberous sclerosis and hypomelanosis of Ito.
Muhammed K; Mathew J
Indian J Dermatol Venereol Leprol; 2007; 73(1):43-5. PubMed ID: 17314448
[TBL] [Abstract][Full Text] [Related]
34. The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.
Wei CC; Hsiao YP; Gau SY; Wu YT; Wu CT; Wu MH; Tsai JD
Dermatology; 2021; 237(3):444-449. PubMed ID: 33032292
[TBL] [Abstract][Full Text] [Related]
35. Initial presentation with dilated cardiomyopathy in a patient of tuberous sclerosis: a rare case report.
Jain D; Kumar V; Kar DP; Prasad SR
Indian Heart J; 2013; 65(1):84-7. PubMed ID: 23438619
[TBL] [Abstract][Full Text] [Related]
36. Scalp fibroma: a rare cutaneous manifestation of tuberous sclerosis.
Sharma B; Prakash S; Sannegowda RB; Panagariya A
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24748136
[TBL] [Abstract][Full Text] [Related]
37. Cellular senescence of angiofibroma stroma cells from patients with tuberous sclerosis.
Toyoshima M; Ohno K; Katsumoto T; Maki H; Takeshita K
Brain Dev; 1999 Apr; 21(3):184-91. PubMed ID: 10372905
[TBL] [Abstract][Full Text] [Related]
38. Oral findings in 58 adults with tuberous sclerosis complex.
Sparling JD; Hong CH; Brahim JS; Moss J; Darling TN
J Am Acad Dermatol; 2007 May; 56(5):786-90. PubMed ID: 17239986
[TBL] [Abstract][Full Text] [Related]
39. The cutaneous manifestations of tuberous sclerosis complex.
Nguyen QD; DarConte MD; Hebert AA
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):321-325. PubMed ID: 30246432
[TBL] [Abstract][Full Text] [Related]
40. Use of mTOR inhibitors (rapalogs) for the treatment of skin changes in tuberous sclerosis complex.
Farges D; Sigg N; Ville D; Martin L
Arch Pediatr; 2022 Dec; 29(5S):5S20-5S24. PubMed ID: 36585067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
